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BACKGROUND: Available data indicate that neutrophils
(PMN) produce a wide range of cytokines with the
potential to modulate immune response. Recent
investigation have shown that interleukin (IL)-15
and IL-18 potentiated several functions of normal
neutrophils. It has been reported that IL-18-induced
cytokine production may be significantly enhanced
by coincident addition of IL-15.
Aims: In the present study we compared the effect of
recombinant human (rh)IL-15 and rhIL-18 as well as
effect of a rhIL-15 and rhIL-18 combination on the
induction secretion of sIL-6Ra and sgp130 by human
neutrophils.
Methods: PMN were isolated from heparinized whole
blood of healthy persons. The PMN were cultured for
18 h at 378C in a humidified incubator with 5% CO2.
rhIL-15 and/or rhIL-18 and lipopolysaccharide were
tested to PMN stimulation. The culture supernatants
of PMN were removed and examined for the presence
of sIL-6R and sgp130 by human enzyme-linked
immunosorbent assay kits. Cytoplasmic protein frac-
tions of PMN were analysed for the presence of sIL-6R
and sgp130 by western blotting using monoclonal
antibodies capable of detecting these proteins. Cells
were lysed and cytoplasmic proteins were electro-
phoresed on sodium dodecyl sulfate-polyacrylamide
gel electrophoresis. The resolved proteins were
transferred onto nitrocellulose and incubated with
the primary monoclonal antibodies anti-sIL-6R and
anti-sgp130. The membranes were incubated at room
temperature with alkaline phosphatase anti-mouse
immunoglobulin G. Immunoreactive protein bans
were visualized by an AP Conjugate Substrate Kit.
Results and conclusion: The results of our investiga-
tion revealed that IL-15 alone, similarly to IL-18, has
no significant ability for the regulation of both
soluble IL-6 receptors, sIL-6R and sgp130, released
by human neutrophils. It is interesting to note that
the secretion of sgp130 was changed after PMN
stimulation with rhIL-15 in the presence of rhIL-18.
The combination of rhIL-15 and rhIL-18 was shown to
induce PMN to secretion relatively higher amounts of
sgp130 compared with the stimulation of PMN with
rhIL-15 alone and rhIL-18 alone. The results obtained
suggest that IL-15 and IL-18, belonging to the
inflammatory cytokines, through the regulation of
sgp130 secretion must be also considered as anti-
inflammatory mediators that may influence the
balance reactions mediated by the IL-6 cytokine
family.
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Introduction
Interleukin (IL)-15 is a pleiotropic cytokine that
shares the biological activities with of IL-2. IL-15
uses both b-chains and g-chains of the IL-2 receptor
for binding and signalling. The IL-15 receptor (IL-
15R) complex also includes a specific a subunit (IL-
15Ra), distinct from the IL-2Ra chain. IL-15R is
expressed on various cells of the immune response,
including T cells and B cells, NK cells and, more
recently, peripheral blood neutrophils.
14
IL-15 plays an important role in both innate and
adaptive immunity. It stimulates antigen-driven T-cell
proliferation, it has co-stimulatory activity for prolif-
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179eration and immunoglobulin (Ig) production by B
cells, and is an efficient activator of natural killer and
lymphokine activated killer (LAK) cells.
2,4
Recent investigation have shown that IL-15 poten-
tiated several functions of normal neutrophils (PMNs)
involved in the innate immune response against
invading pathogens. IL-15 was observed to enhance
phagocytosis, nuclear factor-kB activation and IL-8
production, and to delay apoptosis of these cells.
46
Available data indicate that PMN produce a wide
range of cytokines with potential to modulation of
immune response. The induction of PMN can lead to
the synthesis of cytokines such as IL-1, IL-3, IL-6, IL-8,
IL-12, transforming growth factor-b1 interferon-a,
granulocyte-colony stimulating factor, granulocyte/
macrophage-colony stimulating factor (GM-CSF), tu-
mor necrosis factor (TNF)-a, growth-related onco-
gene (Gro)a, macrophage inflammatory protein
(MIP)-1a and MIP-1b.
4,7 It was also found that
PMN, similar to the other immune cells, are able to
produce naturally occuring proteins that regulate the
activity of certain cytokines in biological fluids or in
tissue culture supernatants.
7 PMNs have the ability to
simultaneous release IL-6 and its regulators: soluble
receptors, sIL-6Ra and sgp130, that control both local
and systemic IL-6-mediated responses.
7,8 Because
various stimuli are able to induce the cellular release
of cytokines and their soluble receptors, it is of
interest to examine the role of other inflammatory
cytokines in the regulation of IL-6 regulatory protein
production. Previous studies in our laboratory have
established that IL-18 is a promising candidate for the
enhanced secretion of IL-6 by human neutrophils but
not for both soluble receptors of IL-6.
8 It is known
that IL-18 does not act alone, but in combination with
other cytokines, such as IL-12 and/or IL-15. Different
combinations of IL-18, IL-12 and IL-15 induce distinct
effects. For example, McInnes et al. reported that IL-
18-induced cytokine production may be significantly
enhanced by coincident addition of IL-15.
9
In the present study we compared the effect of
recombinant human (rh)IL-15 and rhIL-18 as well as
synergistic effect of rhIL-15 with rhIL-18 on the
induction secretion of sIL-6Ra and sgp130 by human
neutrophils. Studies of the interrelations between
these mediators may provide new data on the
inflammatory network cytokine controlled by these
cells.
Materials and methods
Neutrophils and peripheral blood mononuclear cells
(PBMC) were isolated from heparinized (10 U/ml)
whole blood of 15 healthy persons by Gradisol G
gradient (1.115 g/ml). This method enables simulta-
neous separation of two highly purified leukocyte
fractions: mononuclear cells containing 95% lympho-
cytes, and polymorphonuclear cells containing 94%
PMN. The purity of isolated PMN and PBMC was
determined by May/Grunewald/Giemsa staining.
Cells were suspended in the culture medium
(RPMI-1640, autologous serum, penicillin and strep-
tomycin) to provide 5/10
6 cells/cm
3. The PMN were
cultured in 96-well plates (Falcon) for 18 h at 378Ci n
a humidified incubator with 5% CO2 (Nuaire
TM). RhIL-
15 (50 ng/ml; R&D Systems, Minneapolis, USA) and/
or rhIL-18 (50 ng/ml; R&D Systems) and LPS (50 ng/
ml; Sigma) were tested to stimulate secretion by PMN.
After 18 h incubation, the culture supernatants of
PMN were removed and examined for the presence
of sIL-6R and sgp130 by human ELISA kits (R&D
Systems) obtained from BIOKOM.
Cytoplasmic protein fractions of PMN and PBMC
were analysed for the presence of sIL-6R and sgp130
by western blotting using monoclonal antibodies
capable of detecting these proteins, anti-sIL-6R and
anti-sgp130, respectively (R&D Systems, from BIO-
KOM). Cells were lysed directly by sonication, and
cytoplasmic proteins were electrophoresed on so-
dium dodecyl sulfate-polyacrylamide gel electro-
phoresis. The resolved proteins were transferred
onto nitrocellulose and incubated with the primary
monoclonal antibodies anti-sIL-6R and anti-sgp130.
The membranes were incubated at room temperature
with alkaline phosphatase anti-mouse IgG. Immunor-
eactive protein bans were visualized by the AP
Conjugate Substrate Kit.
Results
SIL-6Ra and sgp130 protein expression in
human PMN and PBMC detected by western
blot
We used a specific monoclonal antibody directed
against the intracellular forms of sIL-6R and sgp130
for western blot in PMN and for comparison in
PBMC. As shown in Fig. 1, the antibody in human
unstimulated and LPS-stimulated PMN and PBMC
identified bands of 110 and 55 kDa, respectively,
from each donor.
Western blot analysis showed that the samples of
unstimulated PMN and PBMC contained a 110 kDa
protein that was stained by an anti-sgp130 mono-
clonal antibody. These samples also contained a 55
kDa protein stained by an anti-sIL-6R monoclonal
antibody. The LPS-stimulated PMN and PBMC ex-
pressed a little increased sIL-6R protein in compar-
ison with the unstimulated cell lines. In contrast,
sgp130 expression in unstimulated and LPS-stimu-
lated cells was on the same level. Comparison of sIL-
6R and sgp130 bands indicated that the expression of
sgp130 is more intensive than expression of sIL-6R.
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culture supernatants of PMN detected by
enzyme-linked immunosorbent assay
In the culture supernatants of unstimulated PMN we
observed about 10 times more sgp130 than sIL-6Ra
(23.8 ng/ml and 2.27 ng/ml, respectively).
Similar to rhIL-18, rhIL-15 did not have a significant
effect on the release of sIL-6Ra and sgp130. However,
concentrations of both soluble molecules in the
culture supernatants of rhIL-15-stimulated PMN
were non-significantly higher than those in the
culture supernatants of rhIL-18-stimulated PMN (Fig.
2).
LPS stimulation led to a significant increase in the
sIL-6R secretion by PMN in comparison with unsti-
mulated PMN. We did not observe that kind of
relation in the case of sgp130 secretion by PMN
(Fig. 2).
Release of sIL-6R by PMN stimulated with rhIL-15
and rhIL-18 together were in the levels of sIL-6R in
the culture of PMN stimulated with rhIL-15 only.
In contrast to sIL-6R, secretion of sgp130 by PMN
after stimulation with rhIL-15 and rhIL-18 together
was higher than sgp130 secretion by PMN after
stimulation with rhIL-15 or rhIL-18 alone.
Discussion
Results of our investigation revealed that IL-15,
similarly to IL-18, has no important ability in the
regulation of both soluble IL-6 receptors, sIL-6R and
sgp130, release by human neutrophils.
The lack of effect of these cytokines on the sIL-6R
secretion appears to confirm data demonstrated by
other authors who did not find a significant influence
of most inflammatory cytokines on sIL-6Ra produc-
tion. They demonstrated that IL-1b, IL-6, IL-4, IL-10 or
TNF-a did not affect the sIL-6R production.
10 We have
found that LPS alone stimulated significantly greater
amounts of sIL-6Ra than medium controls, rhIL-15
alone, rhIL-18 alone as well as the combination of
rhIL-15 and rhIL-18.
Similarly, the secretion of sgp130 was independent
of the presence of LPS, rhIL-15 or rhIL-18. It is
interesting to note that the secretion of sgp130 was
changed after PMN stimulation with rhIL-15 in the
presence of rhIL-18. The combination of rhIL-15 and
rhIL-18 was shown to induce PMN to secretion
relatively higher amounts of sgp130 compared with
the stimulation of PMN with rhIL-15 alone and rhIL-
18 alone. Our results indicate that rhIL-15 alone and
rhIL-18 alone, in the used concentrations, do not
FIG. 1. Western blot analysis of sIL-6R and sgp130 proteins expression in human PMN and PBMC cells. We showed detection
of sIL-6R and sgp130 proteins from human unstimulated (line A) and LPS-stimulated (line B), rhIL-15-stimulated (line C), rhIL-
18-stimulated (line D), and rhIL-15 /rhIL-18-stimulated (line E) PMNs. Whole cell lysates were obtained from fresh PMN of
healthy donors. One hundred micrograms of total proteins from PMN were loaded onto a 10% sodium dodecyl sulfate (SDS)-
polyacrylamide gel electrophoresis and transferred to a nitrocellulose ﬁlter. The ﬁlter was incubated with 1:1000 dilution of
respective antibody. Sizes of protein standards are given in kilodaltons. One representative western blot of a few independent
experiments is shown.
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receptor release by human neutrophils.
However, there are available data suggesting a
significant role of IL-15 and IL-18 in regulatory
function of PMN.
5,6 An important role for IL-18 in
the stimulation of PMN activity was recently docu-
mented. It has been found that the capacity of PMN to
release IL-1b, IL-6, IL-8 and TNF-a was enhanced by
the presence of IL-18.
1113 In our previous study we
indicated that IL-18 is also a promising candidate for
the enhanced secretion of IL-6 by human neutrophils.
However, we have not found a significant effect of IL-
18 on the soluble IL-6 receptors.
12 Additionally, we
investigated an effect of IL-15 on the simultaneous
secretion of IL-1b and its soluble receptor type II (sIL-
1RII) by human neutrophils from normal and tu-
mour-bearing hosts. Our observations indicated that
IL-15 induces IL-1b but not sIL-1RII release by these
cells.
13
The observation indicating various actions of
cytokine alone and of cytokine in combination with
others are in agreement with reports of different
authors. For instance, Fehniger et al. demonstrated
that the optimal co-stimulatory monokine combina-
tion for GM-CSF production by human natural killer
cells was IL-18 and IL-15.
14
A probable explanation for the synergistic effect of
IL-18 with IL-15 on the secretion of sgp130 by PMN
may be an influence of these cytokines on their
specific membrane-bound receptor expression. A
recent report characterizing IL-15R and IL-18R ex-
pression on PMN revealed that these cells constitu-
tively express both IL-15R and IL-18R mRNA and
proteins.
5,11 It is possible that IL-15 and IL-18
synergize in inducing sgp130 production by PMN
via induction of their membrane-bound receptor
expression on PMN, IL-18R can be up-regulated by
IL-15 and, conversely, IL-15R may be regulated by the
FIG. 2. The concentrations of sIL-6R and sgp130 in the culture supernatants of LPS-stimulated, rhIL-15-stimulated and rhIL-18-
stimulated PMN. * Statistical difference with unstimulated cells (pB/0.05).
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estimation of membrane-bound receptor expression
are needed to confirm of these suggestions.
In conclusion, the results obtained revealed that IL-
15 and IL-18 belonging to the inflammatory cyto-
kines, through the regulation of sgp130 secretion,
should also be considered anti-inflammatory media-
tors that may influence the balance reactions
mediated by the IL-6 cytokine family, involving also
IL-11, leukemia inhibiting factor (LIF), oncostatin M
(OSM), ciliary neurotrophic factor (CNTF) or cardio-
trophin (CT)-1. However, the clinical studies invol-
ving inflammation and other pathological conditions
may be helpful to explain an importance of these
observations.
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